Navigation Links
Researchers exploit genetic 'co-dependence' to kill treatment-resistant tumor cells
Date:10/21/2009

BOSTON and CAMBRIDGE--Cancer cells fueled by the mutant KRAS oncogene, which makes them notoriously difficult to treat, can be killed by blocking a more vulnerable genetic partner of KRAS, report scientists at the Dana-Farber Cancer Institute and the Broad Institute of Harvard and MIT.

The laboratory results, published by Nature on its Web site as an advanced online publication and later in a print edition, demonstrate a potential advance against many major tumors which, because they harbor the mutant KRAS cancer gene, are highly aggressive and respond poorly to treatment. By targeting the second, more easily inhibited "co-dependent" gene, TBK, the strategy bypasses the so far unfruitful head-on assault against the highly resistant KRAS gene.

"These results represent a new way of targeting oncogenes that have been refractory to standard treatments," said William Hahn, MD, PhD, senior author of the report, of Dana-Farber, the Broad Institute, and Harvard Medical School (HMS). "What's particularly exciting is that this approach is potentially highly specific to cancer cells, and therefore should have little toxicity to normal tissues."

The first author is David Barbie, MD, of the two institutes and HMS.

The mutant KRAS oncogene acts like a broken switch, allowing runaway cell growth in nearly all pancreatic tumors, about 25 percent of colorectal, and 25 to 30 percent of lung cancers. When physicians detect KRAS mutations in a cancer, it usually predicts the patient won't respond well to standard therapies. "If you have a mutant KRAS, we can't use many of our newest drugs," noted Hahn.

For many years, researchers were hopeful that drugs could be designed to shut down KRAS, but this has proven virtually impossible. However, its co-dependent partner, TBK1, encodes a protein kinase -- a type of molecular switch for which many inhibitors already exist. TBK1 is not a cancer-causing gene, but in KRAS-driven tumors, TB
'/>"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Yerkes researchers present at 39th Annual Society for Neuroscience Conference
2. Patent challenges reduce pharmaceutical innovation and productivity, researchers suggest
3. ResearchToolkit.org provides one-stop Web resource for health researchers
4. New Professional Network Brings Chinese Scientists and Researchers into International Community
5. Pitt researchers find candidates for new HIV drugs
6. Researchers discover mechanism that helps humans see in bright and low light
7. New effort to battle antibiotic resistance rallies researchers throughout Harvard University
8. Researchers report benefits of new standard treatment study for rare pediatric brain cancer
9. Researchers identify genes associated with onset age of Parkinsons disease
10. BUSM researchers identify better laser for treating facial spider veins
11. Toronto researchers discover novel circulation in human eye, new glaucoma treatment target
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... ... June 30, 2015 , ... Izenda is proud to acknowledge ... currently attending an accredited American educational institution through its scholarship program. , In ... healthcare, the environment, political campaigns, and a variety of other worldwide trends. Modern ...
(Date:6/30/2015)... ... 2015 , ... Americans report feeling more stressed than ever before. There’s even ... stressed out people right over the edge. , Almost half of Americans report ... night. Sleeping pills now lead the list of the most prescribed medications, despite reported ...
(Date:6/30/2015)... ... June 30, 2015 , ... Scott Purdy, the spokesperson for Dephinitive Systems LLC, ... Purdy stated that the XO stands for eXtra Operability (XO) which was chosen to ... of the Revenue Cycle. , Provider XO, based in Cleveland OH, is part ...
(Date:6/30/2015)... , ... June 30, 2015 , ... “It is never ... of SunGrubbies.com. “We are particularly interested in getting the word out to children ... to surface. We are extremely pleased with our new video which we ...
(Date:6/29/2015)... ... 30, 2015 , ... Sublime Beauty NATURALS® introduces its new USDA Certified Organic ... for natural skincare and even culinary uses, was especially designed for Oil Pulling. ... and Oil Pulling can accomplish this. Oil Pulling is an Ayurvedic practice that is ...
Breaking Medicine News(10 mins):Health News:Izenda Offers Embedded BI and Analytics Scholarship 2Health News:Izenda Offers Embedded BI and Analytics Scholarship 3Health News:Wake UP Happy and Sleep Soundly with Famous Experts with My Wake UP Call® Motivational Alarm Clock® Messages and My Good Night Messages™ - Now Available at Audible! 2Health News:Wake UP Happy and Sleep Soundly with Famous Experts with My Wake UP Call® Motivational Alarm Clock® Messages and My Good Night Messages™ - Now Available at Audible! 3Health News:Dephinitive Systems Is Getting a New Name 2Health News:SunGrubbies.com, a Leading Online Retailer of Sun Protection Products, Joins Effort to Promote Sun Safety 2Health News:SunGrubbies.com, a Leading Online Retailer of Sun Protection Products, Joins Effort to Promote Sun Safety 3Health News:New Product: Transform Wellness and Oral Health With This Ancient Ayurvedic Secret and Organic Product from Sublime Beauty NATURALS® 2
... 13 The American Association of Homes and ... than 60 aging and disability organizations to urge ... a part of health care reform legislation.The groups ... Call today and on a Congressional call-in ...
... CINCINNATI, May 13, 2009 Today, the United States ... favor of The Procter & Gamble Company (P&G) in ... Pharmaceuticals USA, Inc. The positive ruling protects P&G,s ... therapy Actonel(R) (risedronate sodium) tablets. Actonel is commercialized ...
... Irvine, Calif., May 13, 2009 A potential vaccine ... to slow the weakening of muscles associated with inclusion ... The finding brings new hope for IBM patients with ... wrists, forearms or quadriceps. There is no cure for ...
... 2009 Orange County Arthritis Walk(R)IRVINE, Calif., May 13 ... the Arthritis Foundation. The Orange County Great Park ... County Arthritis Walk(R) set to take place on Sunday, ... Foundation,s annual nationwide event to raise funds for arthritis ...
... The decision by the Centers for ... colonography, also known as "virtual" colonoscopy, a radiographic examination ... on the test,s potential as an appropriate option for ... of the primary issues identified by CMS is that ...
... 13 At a congressional hearing today in Washington, ... of Veterans Affairs to immediately expand use of ViziLite(R) ... oral abnormalities that could lead to cancer. David Bethune, ... ZILA ), developer and marketer of ViziLite Plus, addressed ...
Cached Medicine News:Health News:AAHSA Joins Sixty Aging and Disability Groups to Fight for Long-Term Services and Supports in Health Care Reform 2Health News:Procter & Gamble Wins Patent Infringement Lawsuit for Osteoporosis Therapy Actonel 2Health News:Procter & Gamble Wins Patent Infringement Lawsuit for Osteoporosis Therapy Actonel 3Health News:Procter & Gamble Wins Patent Infringement Lawsuit for Osteoporosis Therapy Actonel 4Health News:Vaccine slows progression of skeletal muscle disorder 2Health News:Take a Walk in the Great Park to Benefit the Arthritis Foundation 2Health News:Decision by Medicare's CMS to Deny Coverage for 'Virtual' Colon Cancer Tests Underscores Lack of Evidence on Cancer Prevention 2Health News:Zila & Experts Testify at Congressional Hearing on Innovative Technology for Veterans; Urge Broader Use of ViziLite(R) Plus by VA for Oral Cancer Screening 2Health News:Zila & Experts Testify at Congressional Hearing on Innovative Technology for Veterans; Urge Broader Use of ViziLite(R) Plus by VA for Oral Cancer Screening 3Health News:Zila & Experts Testify at Congressional Hearing on Innovative Technology for Veterans; Urge Broader Use of ViziLite(R) Plus by VA for Oral Cancer Screening 4Health News:Zila & Experts Testify at Congressional Hearing on Innovative Technology for Veterans; Urge Broader Use of ViziLite(R) Plus by VA for Oral Cancer Screening 5Health News:Zila & Experts Testify at Congressional Hearing on Innovative Technology for Veterans; Urge Broader Use of ViziLite(R) Plus by VA for Oral Cancer Screening 6Health News:Zila & Experts Testify at Congressional Hearing on Innovative Technology for Veterans; Urge Broader Use of ViziLite(R) Plus by VA for Oral Cancer Screening 7
(Date:6/29/2015)... , June 29, 2015 BiondVax ... preliminary results from its BVX-006 Phase II clinical trial ... In this trial, M-001 was injected intramuscularly to volunteers ... an administration of the 2014/15 season trivalent influenza vaccine ... safe and well tolerated and induced humoral immune responses, ...
(Date:6/29/2015)... 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) ... Russell 1000 Index, effective June 26, 2015. The Russell ... of the U.S. equity universe. It is a subset ... of the largest securities based on a combination of ... "We are pleased to be added to this important ...
(Date:6/29/2015)... SAN JOSE, Calif. , June 29, 2015 ... its expert medical workstation lineup. The high-powered, multi-functional ... th generation Intel® Haswell Core ... processor. Both provide significant data processing and computing ... visual performance, making the unit well suited for ...
Breaking Medicine Technology:BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 2BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 3ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 2ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 3Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 3
... curtains or parting strip shields ... frame to form a free-standing, ... cleanliness to Class 10/ISO 3. ... lights, and ionizers are configured ...
Inquire...
Inquire...
Inquire...
Medicine Products: